First Pass and Bioavailability Flashcards
Equation for bioavailability?
F = Fa Fg Fh
Fa = fraction absorbed Fg = fraction escaping intestinal metabolism Fh = fraction escaping hepatic metabolism
Implications of intestinal first pass?
- limits value of the oral route (low Fg due to metabolism in enterocytes)
- significant contributor to low and variable F for many oral drugs e.g. statins, HIV protease inhibitors
- can be worsened by transporter interplay
How can first pass metabolism lead to DDIs?
If metabolic enzymes are blocked by drugs, it can increase levels of other drugs which are usually significantly metabolised in the first pass, leading to toxicity
Effects of food on intestinal first pass?
- CYP3A4 is the most abundant P450 enzyme
- grapefruit juice selectively inhibits intestinal CYP3A4 irreversibly
- co-administration of grapefruit juice and CYP3A4 substrate (e.g. statin) can lead to increased plasma levels of the drug, as Fg is higher
Effect of grapefruit juice on simvastatin?
Simvastatin has F < 5%, extensively metabolised. Grapefruit juice causes huge icnrease in Cmax and AUC, so much higher risk of adverse effects
Effect of formulation on bioavailability?
expression of metabolic enzymes changes along the GIT
- immediate release forms have higher exposure the the enzymes higher in the GIT (duodenum, jejunum) so metabolised more
- modified release don’t release until later on in the tract, ileum has less CYP3A4 and colon has none so less metabolism and more absorbed
Factors affecting bioavailability
- incomplete absorption (reduces F) due to permeability or solubility issues
- extensive first pass metabolism
- inhibition of metabolic enzymes in the gut and liver
- competing reactions (enzymatic or non (e.g. complexation))
- effect of surgery and disease (gastric bypass, coeliac, liver cirrhosis)
What must be considered for IM and SC administration in terms of absorption?
characteristics of the drug and the membrane
Properties of the muscle capillary membrane
different to the gut wall - membrane more porous, drugs more readily absorbed via paracellular route
- absorption is generally perfusion rate limited irrespective of Pka and polarity
What usually limits absorption for transdermal administration?
generally permeability rate limited, even for lipophilic compounds (skin is a difficult barrier to cross)
Benefits of pulmonary administration?
no first pass metabolism, very well perfused (however 90% of the dose is usually swallowed so low proportion is deposited in the lungs)